Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sacubitril, quantity: 48.6 mg; valsartan, quantity: 51.4 mg - tablet, film coated - excipient ingredients: hyprolose; microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type a; purified talc; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 4000 - pharmacor sacubitril/valsartan is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sacubitril, quantity: 48.6 mg; valsartan, quantity: 51.4 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; hyprolose; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; purified talc; titanium dioxide; hypromellose; iron oxide yellow; macrogol 4000 - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sacubitril, quantity: 48.6 mg; valsartan, quantity: 51.4 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; sodium starch glycollate type a; purified talc; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; macrogol 4000 - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - valsartan, hydrochlorothiazide - film coated tablet - 160/12.5 mg/mg - angiotensin ii antagonists and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - valsartan, hydrochlorothiazide, micronized - film coated tablet - 320/12.5 mg/mg - angiotensin ii antagonists and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - valsartan hydrochlorothiazide - film coated tablet - 160/25 mg/mg

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - valsartan - film-coated tablet - valsartan 80 mg - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - valsartan - film-coated tablet - valsartan 160 mg - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - valsartan - film-coated tablet - valsartan 320 mg - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - valsartan - film-coated tablet - valsartan 40 mg - agents acting on the renin-angiotensin system